AzTrials
AzTrials

Acute Coronary SyndromeTPD-REACHNCT07171580

Tailoring Post Discharge - Remote Education and Access for Cardiac Health

A study testing Remote Home Monitoring - Education and Remote Home Monitoring - Education and Support in people with Acute Coronary Syndrome and Myocardial Infarction (MI), run by St. Boniface Hospital at 1 site in Canada.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Heart attacks are one of the top causes of death in Canada, with over 2,100 cases treated each year in Manitoba. Even though hospital care has improved, the period after going home is still risky. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Remote Home Monitoring - Education and Remote Home Monitoring - Education and Support
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 siteCanada
Study dates
1 Dec 2025to 30 Apr 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • >18 years old, type 1 myocardial infarction27, resident of Manitoba

Who cannot join

  • Patients unable to consent or fully participate in the study due to:
  • Technology barriers
  • Lack of digital device, internet access or data
  • Discomfort with using technology
  • Communication or language barriers preventing participation
  • Cognitive or mental health limiting informed consent or participation
Show all 21Show fewer
  • Dementia or cognitive impairment
  • Active or severe psychosis or other significant mental health conditions c. Active substance abuse
  • High-risk ACS where patients require more frequent or in person visits a. Cardiac:
  • Coronary
  • Unrevascularizedleftmainormultivessellargeepicardialcoronary artery disease (>2.5mm)
  • Coronary artery bypass surgery (CABG) during index hospitalization ii. Arrhythmias
  • Cardiac arrest during index event/hospitalization (ventricular tachycardia (VT)/ventricular fibrillation (VF), pulseless electrical activity (PEA)) iii. Cardiomyopathy
  • Left ventricular ejection fraction (LVEF) <35% (most recent EF assessment)
  • Cardiogenic shock requiring pressors/inotropes for more than 24 hours
  • Requiring intubation/positive pressure ventilation/hi-flow oxygen for more than 24 hours
  • Switchedfromintravenous(IV)tooral(PO)loopdiureticwithinlast 48 hours
  • Change in PO loop diuretic dose within last 48 homes (home re- start of 80mg or less is allowed)
  • B-type natriuretic peptide (BNP) did not reduce by 30% iv. Cardiac Care Unit (CCU)/Intensive Care Unit (ICU) o Any CCU/ICU stay for more than 24 hours b. Medical: i. any condition with prognosis less than 1 year or a high LACE (Length of stay, Acuity of admission, Comorbidities, Emergency department use) score (>15)28 ii. any medical comorbidity requiring in-person assessment within 2 weeks TPD-REACH PROTOCOL v3 29Aug2025 8 of 17 TPD-REACH: Remote Education and Access for Cardiac Health iii. transition to an alternative living arrangement/compromised independent living iv. need medication adjustment or investigation within 2 weeks c. Social: i. severe financial strain ii. no fixed address or housing instability iii. severe food insecurity iv. significant hearing or vision impairment v. poor health literacy While we aim to promote health equity, patients facing these challenges need more support than this project can offer and should be connected to appropriate services before discharge.
  • Non-atherosclerotic causes of ACS (spontaneous coronary artery dissection, stress- induced cardiomyopathy, myocarditis) as the education and treatment is different
  • Any additional factor preventing full participation in the study

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Shuangbo Liu, MD contact

204-258-1266

sliu@sbgh.mb.ca

Andrea de Haan, BA (Hons) contact

204-258-1001

adehaan@sbgh.mb.ca

Canada1 site
  • St Boniface Hospital

    Winnipeg, Manitoba, R2H 2A6

    Shuangbo Liu, MD, 204-258-1266, sliu@sbgh.mb.ca

    Shuangbo Liu, MD

Other trials in Canada

About this study

Official title: TPD-REACH: Tailoring Post Discharge - Remote Education and Access for Cardiac Health

Heart attacks are one of the top causes of death in Canada, with over 2,100 cases treated each year in Manitoba. Even though hospital care has improved, the period after going home is still risky. Many patients feel anxious and unsure about their recovery, and without enough support, they often end up back in the emergency department (ED). This is an even bigger challenge for people in rural areas, where getting follow-up care can be much harder. Filling these gaps is important to help patients get better and to reduce stress on the healthcare system.

In a previous study, the investigators found that extra support made a big difference: only 8% of participants using a digital health tool returned to the ED within 30 days, compared to 22% of participants without it. Now, the investigators want to expand this study across Manitoba to see if digital health tools can help more people recover safely at home. The investigators will compare two types of follow-up care: education only versus education with extra support (like symptom tracking and virtual appointments). The investigators will look at how this affects hospital visits, mental well-being, and healthcare costs. The goal is to create a better support system for people after a heart attack, leading to healthier recoveries, less strain on hospitals, and better care for Manitobans - no matter where they live.

Read the detailed description

STUDY AIM To evaluate the feasibility and effectiveness of a digital-based short-term post-discharge care program - providing education alone or with additional support - in reducing 30-day unexpected healthcare visits after discharge in low-to-intermediate risk ACS patients in Manitoba, compared to standard care.

STUDY OBJECTIVES Primary Objective: to compare the incidence of 30-day unexpected healthcare visits among low-intermediate risk ACS patients in Manitoba who receive education and support or education alone via a DHT, versus those receiving standard care.

Secondary Objectives: will examine 3 spheres of outcomes, across the 3 study groups:

  1. Clinical Outcomes i. To examine and compare the occurrence of major adverse cardiovascular events (MACE) as a composite and individual components, including death, myocardial infarction (MI), repeat revascularization, readmission, stroke, vascular complications, or new HF requiring admission, at 30 days post-discharge ii. To explore the feasibility and acceptability of implementing a digital health platform intervention (DHPI) for extended short-term care for low-intermediate risk ACS patients in Manitoba at 30 days post-discharge iii. To identify patient-specific factors (e.g., home location, age, sex, gender) that may influence the effectiveness of the DHPI on healthcare utilization and recovery outcomes at 30 days post-discharge
  2. Psychosocial Outcomes i. To evaluate patient-reported outcomes of mental health (e.g., anxiety, depression), quality of life, and satisfaction with care at 30 days post-discharge ii. To study the impact of the DHPI on patient activation measure, a marker of patients' knowledge, skills and confidence in self-managing their health at 30 days post-discharge iii. To assess patient satisfaction with the DHPI, focusing on usability, accessibility, and overall experience during recovery at 30 days post-discharge
  3. Cost i. To conduct a cost-effectiveness analysis comparing the digital health platform interventions (education and support vs education alone) to standard care, examining healthcare resource utilization and potential cost savings at 30 days post-discharge

STUDY DESIGN This study is a single-center, pragmatic randomized controlled trial designed to evaluate post discharge support for low-intermediate risk ACS patients. Before hospital discharge, patients will be screened for eligibility. At discharge, eligible patients will be randomly assigned to one of three groups: (1) standard care; (2) education only and (3) education and support. The pragmatic design ensures that all study procedures-including recruitment, intervention, and follow-up-are closely integrated with routine clinical care, with minimal deviations beyond the study intervention itself. This approach enhances real-world applicability, making it easier to implement findings into everyday clinical practice. Study design and implementation are guided by the PRagmatic Explanatory Continuum Indicator Summary 2 (PRECIS-2) tool to ensure clinical relevance and feasibility. Full Research Ethics Board and institutional review board approval will be obtained before the study begins. The study will be registered on ClinicalTrials.gov.

STUDY INTERVENTION Remote Home Monitoring (RHM) is a secure, web-based, digital health application designed to support patients in their recovery. When used to its fullest extent, patients can access tailored education, real-time monitoring, track their health, and connect with care providers. RHM aims to improve patient knowledge, encourage self-management, and provide timely clinical support to reduce unexpected healthcare visits.

Study participants will be randomly assigned to one of three groups: standard care arm (SA), RHM education only arm (EA), RHM full intervention arm with education and support (FA). Before discharge, all patients will be provided with a blood pressure monitor and oximeter, allowing them to track their blood pressure and blood oxygen saturation at home. This not only supports ongoing health monitoring but also empowers patients to take an active role in managing their health.

(A) Standard Care Arm: Patients will receive standard education in hospital. They will not be registered in the RHM application or receive education modules, health care interviews or virtual appointments.

(B) Education Only Arm: Patients will be enrolled in the RHM application, allowing tracking of their access to the education modules. They will start with an introductory module, followed by one module per day for a total of 7 modules covering key topics related to ACS (Cardiac Rehabilitation, Heart Attack Risk Factors, Living with Heart Disease, Medications, Mental Health, Nutrition, Physical Activity). Participants that have atrial fibrillation will receive an additional education module on that topic, and participants with heart failure with receive an additional education module relating to that topic. Engagement for modules will be monitored, if any patient misses more than one module, they will be contacted for a reminder and troubleshooting. Participants will have access to the RHM education modules for 30 days post hospital discharge.

(C) Full Intervention Arm: Patients will be enrolled in the RHM application. Patients will receive all interventions in the EA, and in addition, they will receive support through the RHM application. Patients will complete health care surveys three times a week, covering topics such as symptoms, vital signs, medication side effects, functional status, and whether they have questions or concerns. Patients will have three scheduled virtual appointments with a cardiologist on 1 day, 1 week, 2 weeks after discharge. If a patient misses a survey, they will be prompted. Patients will also have access to unscheduled health care interviews, virtual appointments, and a hotline for additional questions or concerns. Participants will have access to the RHM education modules and program support for 30 days post hospital discharge.

Participants will be asked to complete questionnaires at three time points: baseline (link to access the questionnaires via REDCap will be sent on the day of hospital discharge), 14 days post discharge, and 30 days post discharge. These include validated tools to assess psychosocial well-being (GAD-7, PHQ-9, EQ-5D-5L, EQ-VAS) and patient activation (PAM-13). They will also complete surveys that cover demographics, health literacy, care transition, unexpected healthcare visits, and satisfaction with care. Responses will be securely collected and stored using REDCap, ensuring both convenience for participants and data integrity for analysis.

Being tested
Remote Home Monitoring - Education, Remote Home Monitoring - Education and Support
Keywords
Percutaneous Coronary Intervention, Education, Support, Digital Health Tool, Remote Home Monitoring
Medical subject headings
Acute Coronary Syndrome, Myocardial Infarction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Remote Home Monitoring - EducationOther

    A virtual platform will be used to provide education to ACS patients post discharge.

  • Remote Home Monitoring - Education and SupportOther

    A virtual platform will be used to provide education and support to ACS patients post discharge.

Study groups in NCT07171580
Study groupRoleWhat they receive
Standard Care (SA)No interventionPatients will receive standard education in hospital. They will not be registered in the RHM application or receive education modules, health care interviews or virtual appointments.
Education Only (EA)ExperimentalPatients will be enrolled in the RHM application, allowing tracking of their access to the education modules. They will start with an introductory module, followed by one module per day for a total of 7 modules covering key topics related to ACS (Cardiac Rehabilitation, Heart Attack Risk Factors, Living with Heart Disease, Medications, Mental Health, Nutrition, Physical Activity). Participants that have atrial fibrillation will receive an additional education module on that topic, and participants with heart failure with receive an additional education module relating to that topic. Engagement for modules will be monitored, if any patient misses more than one module, they will be contacted for a reminder and troubleshooting. Participants will have access to the RHM education modules for 30 days post hospital discharge.
Receives: Other: Remote Home Monitoring - Education
Full InterventionExperimentalPatients will be enrolled in the RHM application. Patients will receive all interventions in the EA, and in addition, they will receive support through the RHM application. Patients will complete health care surveys three times a week, covering topics such as symptoms, vital signs, medication side effects, functional status, and whether they have questions or concerns. Patients will have three scheduled virtual appointments with a cardiologist on 1 day, 1 week, 2 weeks after discharge. If a patient misses a survey, they will be prompted. Patients will also have access to unscheduled health care interviews, virtual appointments, and a hotline for additional questions or concerns. Participants will have access to the RHM education modules and program support for 30 days post hospital discharge.
Receives: Other: Remote Home Monitoring - Education and Support

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of Unexpected Healthcare Visits

    30-day unexpected healthcare visits (including emergency department, urgent care, walk in clinic or nursing station)

    Measured: 30 days post hospital discharge

Secondary outcomes (10)
  1. Composite of Events

    Composite of death, MI, repeat revascularization, readmission, stroke, vascular complication, new HF or needing admission

    Measured: 30 days post hospital discharge

  2. Individual Components of Composite Events

    Individual components of death, MI, repeat revascularization, readmission, stroke, vascular complication, new HF or needing admission

    Measured: 30 days post hospital discharge

  3. Individual Components of Composite Unexpected Healthcare Visits

    Individual components of unexpected healthcare visits including emergency department, urgent care, walk in clinic or nursing station

    Measured: 30 days post hospital discharge

  4. PAM-13 - Patient Activation Measure

    This survey will measure patient knowledge, skills, and confidence in self- managing their health

    Measured: Baseline (day of hospital discharge), 14 days post hospital discharge, and 30 days post hospital discharge

  5. Generalized Anxiety Disorder (GAD) - 7

    GAD-7 this survey measures self-report anxiety symptoms with a total score from 0-21. Lower scores indicate fewer anxiety symptoms

    Measured: Baseline (day of hospital discharge), 14 days post hospital discharge, and 30 days post hospital discharge

  6. Patient Health Questionnaire (PHQ) - 9

    PHQ-9 this survey measures self-report depression symptoms with a total score from 0-27. Lower scores indicate fewer depressive symptoms

    Measured: Baseline (day of hospital discharge), 14 days post hospital discharge, and 30 days post hospital discharge

  7. EQ-5D-5L - Health Related Quality of Life

    EQ-5D-5L - This survey will measure 5 aspects of self-reported quality of life for patients. Each component is scored from 1-5 with a total score of the tool from 5-25. Lower scores indicate better outcomes

    Measured: Baseline (day of hospital discharge), 14 days post hospital discharge, and 30 days post hospital discharge

  8. EQ-VAS - Health Related Quality of Life

    EQ-VAS - this survey measures self-report quality of life on a scale of 0-100. Higher scores indicate better self reported quality of life

    Measured: Baseline (day of hospital discharge), 14 days post hospital discharge, and 30 days post hospital discharge

  9. Patient Satisfaction Questionnaire

    Patient Satisfaction with the care received and the study program

    Measured: At 30 days post hospital discharge

  10. Overall Healthcare Cost Savings per Patient

    Average difference in healthcare costs between the study arms based on healthcare utilization.

    Measured: 30 days post hospital discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Sep 2025
  2. Study start1 Dec 2025 (estimated)
  3. Primary completion30 Nov 2026 (estimated)
  4. Study completion30 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
Comparing 3 interventional groups: 1) Standard Care 2) Education Only 3) Full Intervention (Education and Support)
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07171580
Sponsor's protocol ID
TPD-REACH Protocol
Acronym
TPD-REACH
Status last verified
Sep 2025
First submitted
30 Aug 2025
Last updated
12 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Remote Home Monitoring - Education and Remote Home Monitoring - Education and Support in people with Acute Coronary Syndrome and Myocardial Infarction (MI), run by St. Boniface Hospital at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 21 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 12 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Shuangbo Liu, MD (204-258-1266, sliu@sbgh.mb.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of Unexpected Healthcare Visits (time frame: 30 days post hospital discharge). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Sep 2025; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in